表紙
市場調查報告書

泌尿科設備製造商前20大企業 (2020年) :Karl Storz,Stryker Corporation,Medtronic,Intuitive Surgical,Boston Scientific Corporation,Cook Medical、其他

Top 20 Urology Devices Manufacturers 2020: Karl Storz, Stryker Corporation, Medtronic, Intuitive Surgical, Boston Scientific Corporation, Cook Medical, Other Companies

出版商 Visiongain Ltd 商品編碼 927177
出版日期 內容資訊 英文 210 Pages
商品交期: 最快1-2個工作天內
價格
泌尿科設備製造商前20大企業 (2020年) :Karl Storz,Stryker Corporation,Medtronic,Intuitive Surgical,Boston Scientific Corporation,Cook Medical、其他 Top 20 Urology Devices Manufacturers 2020: Karl Storz, Stryker Corporation, Medtronic, Intuitive Surgical, Boston Scientific Corporation, Cook Medical, Other Companies
出版日期: 2019年12月19日內容資訊: 英文 210 Pages
簡介

2018年的泌尿科設備市場規模估計69億美元,預計從2018年到2029年,以6.1%的年複合成長率擴大。尿失禁市場,在2018年的該市場中獲得33.8%的佔有率,成為最大的市場區隔。

本報告提供全球泌尿科設備市場相關調查,市場概要,市場成長的影響要素分析,及SWOT分析等,製造商前20大企業的簡介,為您概述為以下內容。

第1章 報告概要

第2章 泌尿科設備市場簡介

  • 泌尿科設備市場定義
  • 泌尿科設備市場次市場定義
    • 尿失禁(UI)市場定義
    • 良性前列腺肥大症的市場定義
    • 前列腺癌次市場定義
    • 腎臟結石次市場定義
  • 市場成長的推動要素、障礙
    • 市場成長促進因素
    • 阻礙市場成長要素

第3章 SWOT分析

第4章 泌尿科設備企業的前20大企業

  • 泌尿科設備企業的主要20家公司的銷售額佔有率分析

第5章 主要企業的簡介

  • KARL STORZ SE & Co KG
    • 公司概要
    • 產業概要
    • 地理存在感
    • 提供產品
    • 開發平台分析
    • 財務概要
    • 策略性開發
    • SWOT分析
  • Stryker Corporation
  • Medtronic
  • Intuitive Surgical Inc.
  • Boston Scientific Corporation
  • Cook Medical
  • Siemens Healthineers AG
  • Olympus
  • Coloplast
  • Teleflex
  • Endo Pharmaceuticals
  • Healthtronics
  • Lumenis
  • C R Bard: (Becton, Dickinson)
  • B.Braun Medical
  • Fresenius Medical
  • Dornier MedTech GmbH
  • 日機裝
  • UROLOGIX
  • Urotech GmbH

第6章 結論、建議

目錄
Product Code: PHA0644

In 2018, the urology devices market is estimated at $6.9bn and is expected to grow at a CAGR of 6.1% from 2018 to 2029. The urinary incontinence market dominated the market in 2018 and accounted for 33.8% of the urology devices market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 210-page report you will receive 84 charts - all unavailable elsewhere.

The 210-page report provides clear detailed insight into the top 20 urology devices manufacturers. Discover the key drivers and challenges affecting the market.

Report Scope

Profiles of leading urology devices manufacturers:

  • B.Braun Medical
  • Boston Scientific Corporation
  • C R Bard
  • Coloplast
  • Cook Medical
  • Dornier MedTech GmbH
  • Endo Pharmaceuticals
  • Fresenius Medical
  • Healthtronics
  • Intuitive Surgical Inc
  • KARL STORZ SE & Co KG
  • Lumenis
  • Medtronics
  • NIKKISO CO. LTD:
  • Olympus Corporation
  • Siemens Healthineers
  • Stryker Corporation
  • Teleflex
  • UROLOGIX
  • Urotech GmbH

The report provides information and discussion on:

  • Company overview & analysis
  • Product offerings
  • Financial information
  • Strategic developments
  • SWOT analysis

Key questions answered by this report:

  • What are the drivers and restraints of the urology devices market?
  • Who are the leading urology devices manufacturers?
  • What are their products, developmental candidates and therapeutic applications?
  • What is the status of the clinical trials they are undergoing?
  • What are the latest news and developments from those companies?

Visiongain's study is intended for anyone requiring commercial analyses for the Top 20 Urology Devices Manufacturers 2020. You find data, trends and predictions.

Buy our report today Top 20 Urology Devices Manufacturers 2020: Karl Storz, Stryker Corporation, Medtronic, Intuitive Surgical, Boston Scientific Corporation, Cook Medical, Other Companies.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Global Urology Device Market Overview
  • 1.2 Why You Should Read This Report
  • 1.3 Who is This Report For?
  • 1.4 Methodology
    • 1.4.1 Primary Research
    • 1.4.2 Secondary Research
    • 1.4.3 Market Evaluation & Forecasting Methodology
  • 1.5 Frequently Asked Questions (FAQ)
  • 1.6 Associated Visiongain Reports
  • 1.7 About Visiongain

2. Introduction to the Urology Device Market

  • 2.1 Urology Device Market Definition
  • 2.2 Urology Device Market Submarkets Definition
    • 2.2.1 Urinary Incontinence (UI) Market Definition
    • 2.2.2 Benign Prostatic Hyperplasia Market Definition
    • 2.2.3 Prostate Cancer Submarket Definition
    • 2.2.4 Kidney Stone Submarket Definition
  • 2.3 Market Drivers and Barriers
    • 2.3.1 Market Drivers
      • 2.3.1.1 High Target Population
      • 2.3.1.3 Technological Innovations
      • 2.3.1.4 Favourable Government Healthcare Policy and Funding
    • 2.3.2 Market Restrainers
      • 2.3.2.1 Safety Concerns
      • 2.3.2.2 Barrier: Higher cost

3. SWOT Analysis of the Urology Device Market

4. Leading 20 Urology Device Companies

  • 4.1 Leading 20 Urology Company Sales Share Analysis 2018

5. Key Company Profiles

  • 5.1 KARL STORZ SE & Co KG
    • 5.1.1 Company Overview
    • 5.1.2. Business Overview
    • 5.1.3 Geographical Presence
    • 5.1.4 Product Offerings
    • 5.1.5 Pipeline Analysis
    • 5.1.6 Financial Overview
    • 5.1.7 Strategic Developments
      • 5.1.7.1 Medicaroid and KARL STORZ
      • 5.1.7.2 KARL STORZ Endoscopy Enters into Distribution Agreement with LiveData
      • 5.1.7.3 Recent Events
    • 5.1.8. SWOT Analysis
      • 5.1.8.1 Strengths
      • 5.1.8.2 Weaknesses
      • 5.1.8.3 Opportunities
      • 5.1.8.4 Threats
  • 5.2 Stryker Corporation
    • 5.2.1 Company Overview
    • 5.2.2 Business Overview
    • 5.2.3 Geographical Presence
    • 5.2.4 Product Offerings
    • 5.2.5 Financial Information
    • 5.2.6 Strategic Developments
    • 5.2.7. SWOT Analysis
      • 5.2.7.1 Strengths
      • 5.2.7.2 Weaknesses
      • 5.2.7.3 Opportunities
      • 5.2.7.4 Threats
  • 5.3 Medtronic
    • 5.3.1 Company Overview
    • 5.3.2 Business Overview
    • 5.3.3 Geographical Presence
    • 5.3.4 Product Offerings
    • 5.3.5 Pipeline Product Overview
    • 5.3.6 Financial Overview
    • 5.3.7 Strategic Developments
    • 5.3.8 SWOT Analysis
      • 5.3.8.1 Strengths
      • 5.3.8.2 Weaknesses
      • 5.3.8.3 Opportunities
      • 5.3.8.4 Threats
  • 5.4 Intuitive Surgical Inc.
    • 5.4.1 Company Overview
    • 5.4.2 Business Overview
    • 5.4.3 Geographical Presence
    • 5.4.4 Product Offerings
    • 5.4.5 Pipeline Product Overview
    • 5.4.6 Financial Overview
    • 5.4.7 SWOT Analysis
      • 5.4.7.1 Strengths
      • 5.4.7.2 Weaknesses
      • 5.4.7.3 Opportunities
      • 5.4.7.4 Threats
    • 5.4.8 Strategic Developments
  • 5.5 Boston Scientific Corporation
    • 5.5.1 Company Overview
    • 5.5.2 Business Overview
    • 5.5.3 Geographical Presence
    • 5.5.4 Product Offerings
    • 5.5.5 Financial Information
    • 5.5.6 Strategic Developments
    • 5.5.7 SWOT Analysis
      • 5.5.7.1 Strengths
      • 5.5.7.2 Weaknesses
      • 5.5.7.3 Opportunity
      • 5.5.7.4 Threats
  • 5.6 Cook Medical
    • 5.6.1 Company Overview
    • 5.6.2 Business Overview
    • 5.6.3 Geographical Presence
    • 5.6.4 Product Offerings
    • 5.6.5 Strategic Developments
    • 5.6.6 SWOT Analysis
      • 5.6.6.1 Strengths
      • 5.6.6.2 Weaknesses
      • 5.6.6.3 Opportunities
      • 5.6.6.4 Threats
  • 5.7 Siemens Healthineers AG
    • 5.7.1 Company Overview
    • 5.7.2 Business Overview
    • 5.7.3 Geographical Presence
    • 5.7.4 Financial Information
    • 5.7.5 Strategic Developments
    • 5.7.6 SWOT Analysis
      • 5.7.6.1 Strengths
      • 5.7.6.2 Weaknesses
      • 5.7.6.3 Opportunities
      • 5.7.6.4 Threats
  • 5.8 Olympus Corporation
    • 5.8.1 Company Overview
    • 5.8.2 Business Overview
    • 5.8.3 Product Offerings
    • 5.8.4 Pipeline Product Overview
    • 5.8.5 Financial Overview
    • 5.8.6 SWOT Analysis
      • 5.8.6.1 Strengths
      • 5.8.6.2 Weaknesses
      • 5.8.6.3 Opportunities
      • 5.8.6.4 Threats
    • 5.8.7 Strategic Developments
      • 5.8.7.1 M&A
      • 5.8.7.2 Recent Development
  • 5.9 Coloplast
    • 5.9.1 Company Overview
    • 5.9.2 Business Overview
    • 5.9.3 Geographic Coverage
    • 5.9.4 Major Products Offerings
    • 5.9.5 Pipeline Overview
    • 5.9.6 Financial Overview
    • 5.9.7 SWOT Analysis
      • 5.9.7.1 Strengths
      • 5.9.7.2 Weaknesses
      • 5.9.7.3 Opportunities
      • 5.9.7.4 Threats
    • 5.9.8 Strategic Developments
      • 5.9.8.1 M&A
      • 5.9.8.2 Recent Developments
    • 5.10 Teleflex
    • 5.10.1 Company Overview
    • 5.10.2 Business Overview
    • 5.10.3 Geographical Coverage
    • 5.10.4 Products offerings
    • 5.10.5 Pipeline Overview
    • 5.10.6 Financial Information
    • 5.10.7 Strategic Development
      • 5.10.7.1 M&A
      • 5.10.7.2 Recent Developments
    • 5.10.8 SWOT Analysis
      • 5.10.8.1 Strengths
      • 5.10.8.2 Weaknesses
      • 5.10.8.3 Opportunities
      • 5.10.8.4 Threats
  • 5.11 Endo Pharmaceuticals
    • 5.11.1 Company Overview
    • 5.11.2 Business Overview
    • 5.11.4 Product Offerings
    • 5.11.5 Pipeline Overview
    • 5.11.6 Financial Overview
    • 5.11.7 Strategic Development
      • 5.11.7.1 M&A
      • 5.11.7.2 Recent Developments
  • 5.12 Healthtronics
    • 5.12.1 Company Overview
    • 5.12.2 Business Overview
    • 5.12.3 Geographical Coverage
    • 5.12.4 Product Offerings
    • 5.12.5 SWOT Analysis
      • 5.12.5.1 Strengths
      • 5.12.5.2 Weaknesses
      • 5.12.5.3 Opportunities
      • 5.12.5.4 Threats
    • 5.12.6 Financial Overview
    • 5.12.7 M&A
  • 5.13 Lumenis
    • 5.13.1 Company Overview
    • 5.13.2 Business Overview
    • 5.13.3 Major Products Offerings
    • 5.13.4 Financial Overview
    • 5.13.5 SWOT Analysis
      • 5.13.5.1 Strengths
      • 5.13.5.2 Weaknesses
      • 5.13.5.3 Opportunities
      • 5.13.5.4 Threats
    • 5.13.6 Strategic Development
      • 5.13.6.1 Recent Development
  • 5.14 C R Bard: (Becton, Dickinson)
    • 5.14.1 Company Overview
    • 5.14.2 Business Overview
    • 5.14.3 Product Offerings
    • 5.14.4 Geographic Presence
    • 5.14.5 Pipeline Product Overview
    • 5.14.6 SWOT Analysis
      • 5.14.6.1 Strengths
      • 5.14.6.2 Weaknesses
      • 5.14.6.3 Opportunities
      • 5.14.6.4 Threats
  • 5.15 B.Braun Medical
    • 5.15.1 Company Overview
    • 5.15.2 Business Overview
    • 5.15.3 Product Offerings
    • 5.15.4 Pipeline Products
    • 5.15.5 Financial Overviews
    • 5.15.6 Recent Developments
  • 5.16 Fresenius Medical
    • 5.16.1 Company Overview
    • 5.16.2 Business Overview
    • 5.16.3 Product Offerings
    • 5.16.4 Geographic Presence
    • 5.16.5 Financial Overview
    • 5.16.6 SWOT Analysis
      • 5.16.6.1 Strengths
      • 5.16.6.2 Weaknesses
      • 5.16.6.3 Opportunities
      • 5.16.6.4 Threats
  • 5.17 Dornier MedTech GmbH
    • 5.17.1 Company Overview
    • 5.17.2 Business Overview
    • 5.17.3 Product Offerings
    • 5.17.4 Geographic Presence
    • 5.17.5 Financial Overview: NA
  • 5.18 NIKKISO CO. LTD
    • 5.18.1 Company Overview
    • 5.18.2 Business Overview
    • 5.18.3 Product offerings
    • 5.18.4 Geographical Presence
    • 5.18.5 Financial Overview
    • 5.18.6 SWOT Analysis
      • 5.18.6.1 Strengths
      • 5.18.6.2 Weaknesses
      • 5.18.6.3 Opportunities
      • 5.18.6.4 Threats
  • 5.19 UROLOGIX
    • 5.19.1 Company Overview
    • 5.19.2 Business Overview
    • 5.19.3 Products
    • 5.19.4 Financial Overview
    • 5.19.5 Recent Development
  • 5.20 Urotech GmbH
    • 5.20.1 Company Overview
    • 5.19.2 Business Overview
    • 5.20.3 Product Offerings
    • 5.20.4 Financial Overview

6. Conclusions and Recommendations

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain report evaluation form

List of Tables

  • Table 3.1 Global Urology Device Market SWOT Analysis
  • Table 4.1 Leading 20 Urology Companies Sales Share 2018 (Ranking, Company, FY2018 Total Company Sales US$m, Share of FY2018 Total Sales from Sales in the Market US$m)
  • Table 5.1 Karl Stroz Se & Co KG
  • Table 5.2 KARL STORZ SE & Co KG - Number of Pipeline Product by Development Stage
  • Table 5.3 KARL STORZ SE & Co KG - Number of Pipeline Products by Category
  • Table 5.4 KARL STORZ SE & Co KG - Number of Pipeline Products by Territory
  • Table 5.5 Stryker Corporation
  • Table 5.6 Medtronic
  • Table 5.7 Medtronic: Number of Pipeline Product by Indications
  • Table 5.8 Medtronic: Number of Pipeline Products by Therapeutic Area
  • Table 5.9 Intuitive Surgical
  • Table 5.10 Intuitive Surgical: Pipeline Product Overview
  • Table 5.11 Boston Scientific Corporation
  • Table 5.12 Cook Medical
  • Table 5.13 Siemens Healthineers AG
  • Table 5.14 Olympus Corporation
  • Table 5.15 Olympus Corporation: Number of Pipeline Products by Category
  • Table 5.16 Olympus Corporation: Number of Pipeline Products by Type
  • Table 5.17 Olympus Corporation: Number of Pipeline Products by Territory
  • Table 5.18 Coloplast
  • Table 5.19 Coloplast: Number of Pipeline Products by Development Stage
  • Table 5.20 Coloplast: Number of Pipeline Products by Category
  • Table 5.21 Coloplast: Number of Pipeline Products by Territory
  • Table 5.22 Teleflex
  • Table 5.23 Teleflex : Number of Pipeline Products by Development Stage
  • Table 5.24 Teleflex: Number of Pipeline Products by Category
  • Table 5.25 Teleflex: Number of Pipeline Products by Territory
  • Table 5.26 Endo Pharmaceuticals
  • Table 5.27 Endo Pharmaceutical: Number of Pipeline Products by Category
  • Table 5.28 Endo Pharmaceutical: Number of Pipeline Products by Indication
  • Table 5.29 Endo Pharmaceutical: Number of Pipeline Products by Development Stage
  • Table 5.30 Healthtronics
  • Table 5.31 Lumenis
  • Table 5.32 CR Bard: Becton, Dickinson
  • Table 5.33 BD: Number of Pipeline Products by Type
  • Table 5.34 BD: Number of Pipeline Products by Territory
  • Table 5.35 BD: Number of Pipeline Products by Development Stage
  • Table 5.36 B.Braun Medical
  • Table 5.37 Braun: Number of Pipeline Products by Type
  • Table 5.38 Fresenius Medical
  • Table 5.39 Dornier MedTech GmbH
  • Table 5.40 Nikkiso Co.Ltd
  • Table 5.41 Urologixo.Ltd
  • Table 5.42 Urotech GmbH

List of Figures

  • Figure 5.1 Stryker Corporation: Financial Overview Net Sales, 2014-2018
  • Figure 5.2 Stryker Corporation: Financial Overview Net Earning, 2014-2018
  • Figure 5.3 Medtronic: Financial Overview, Net Sales, 2014-2018
  • Figure 5.4 Medtronic: Financial Overview, Operating Profit, 2014-2018
  • Figure 5.5 Medtronic: Financial Overview Net Income, 2014-2018
  • Figure 5.6 Medtronic: Financial Overview Divisionwise Performance, 2014-2018
  • Figure 5.7 Medtronic: Net Sales by Market Geography (2018)
  • Figure 5.8 Intuitive Surgical: Financial Overview Net Sales, 2013-2017
  • Figure 5.9 Intuitive Surgical: Financial Overview Net Income, 2013-2017
  • Figure 5.10 Intuitive Surgical: Net Sales by Market Geography (2017)
  • Figure 5.11 Boston Scientific Corporation: Revenue, 2013-2017
  • Figure 5.12 Boston Scientific Corporation: Net Income, 2013-2017
  • Figure 5.13 Boston Scientific Corporation: Net Sales by Country (2018)
  • Figure 5.14 Siemens Healthineers AG: Revenue 2014-2018
  • Figure 5.15 Siemens Healthineers AG: Net Income, 2015-2018
  • Figure 5.16 Siemens Healthineers AG: Revenue by Region (2018)
  • Figure 5.17 Olympus Corporation: Net Sales, 2014-2018
  • Figure 5.18 Olympus Corporation: Operating Profit 2014-2018
  • Figure 5.19 Olympus Corporation: Revenue by Region (2018)
  • Figure 5.20 Olympus Corporation: Revenue By Product Sub Segment (2018)
  • Figure 5.21 Olympus Corporation: Revenue by Product Segment (2018)
  • Figure 5.22 Coloplast: Net Sales, 2014-2018
  • Figure 5.23 Coloplast: Operating Profit, 2014-2018
  • Figure 5.24 Coloplast: Revenue by Region (2018)
  • Figure 5.25 Teleflex: Net Sales, 2013-2017
  • Figure 5.26 Teleflex: Revenue by Categories (2017)
  • Figure 5.27 Teleflex: Revenue by Region (2017)
  • Figure 5.28 Endo Pharmaceutical: Net Sales, 2014-2018
  • Figure 5.29 BD: Financial Overview- Revenue, 2014-2018
  • Figure 5.30 BD: Financial Overview- Net Sales, 2014-2018
  • Figure 5.31 BD: Financial Overview- Operating Profit, 2014-2018
  • Figure 5.32 BD: Revenue by Product Category (2018)
  • Figure 5.33 Braun: Financial Overview- Revenue, 2014-2017
  • Figure 5.34 Fresenius Medical: Financial Overview- Operating Profit, 2014-2018
  • Figure 5.35 Fresenius Medical: Financial Overview- Revenue, 2014-2018
  • Figure 5.36 Fresenius Medical: Financial Overview- Net Profit, 2014-2018
  • Figure 5.37 Nikkiso Co.Ltd: Financial Overview- Net Sales, 2014-2018
  • Figure 5.38 Nikkiso Co.Ltd: Financial Overview- Operating Profit, 2014-2018
  • Figure 5.39 Nikkiso Co.Ltd: Financial Overview- Medical Division Sales, 2016-2017, 2020F
  • Figure 5.40 Nikkiso Co.Ltd: Revenue by Region, 2017

List of Companies and Organisations Mentioned in the Report:

  • Abbott Laboratories
  • AlloSource
  • American Urological Association Foundation (AUAF)
  • Apama Medical Inc.
  • ARCA Biopharma
  • Arthrex, Inc.
  • Augmenix, Inc.
  • B.Braun Medical
  • Boston Scientific Corporation
  • C R Bard
  • Claret Medical, Inc.
  • Coloplast
  • Conmed
  • Cook Medical
  • Cryterion Medical, Inc.
  • DePuy Orthopedics, Inc.
  • DePuy Spine, Inc.
  • Dextera Surgical Inc
  • Dornier MedTech GmbH
  • Endo Pharmaceuticals
  • Entellus Medical, Inc.
  • Food and Drug Administration (FDA)
  • Fresenius Medical
  • Globus Medical, Inc.
  • Healthtronics
  • Hill-Rom
  • Intuitive Surgical Inc
  • Johnson & Johnson
  • JustRight Surgical, LLC
  • K2M Group Holdings, Inc.
  • KARL STORZ Endoscopy-America, Inc.
  • KARL STORZ SE & Co KG
  • Linvatec
  • Lumenis
  • Medical University of South Carolina (MUSC)
  • Medtronic Sofamor Danek, Inc
  • Medtronics
  • Mercy
  • Millipede, Inc.
  • NIKKISO CO. LTD:
  • Nuvasive, Inc.
  • Olympus Corporation
  • Olympus Optical Co. Ltd.
  • Penumbra
  • Royal Philips
  • Securus Medical Group
  • Siemens Healthineers
  • Smith & Nephew
  • STERIS plc
  • Stryker Corporation
  • Teleflex
  • Therapeutic Goods Administration (TGA)
  • TransEnterix, Inc.
  • University of California (UCLA)
  • UROLOGIX
  • Urotech GmbH
  • VENITI, Inc.
  • Verb Surgical Inc.
  • Zelegent, Inc.
  • Zell Medical
  • Zimmer Biomet